| PCS-2023 > 3 > 3E > 3E0 > 3E08 |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E08 | Introduction, Heart | |
3E080 | Open | |
3E0801 | Thrombolytic | |
3E08016 | Introduction of Recombinant Human-activated Protein C into Heart, Open | |
3E08017 | Introduction of Other Thrombolytic into Heart, Open Approach | |
3E080G | Other Therapeutic Substance | |
3E080GC | Introduction of Other Therapeutic Substance into Heart, Open Approach | |
3E080K | Other Diagnostic Substance | |
3E080KZ | Introduction of Other Diagnostic Substance into Heart, Open Approach | |
3E080P | Platelet Inhibitor | |
3E080PZ | Introduction of Platelet Inhibitor into Heart, Open Approach | |
3E083 | Percutaneous | |
3E0831 | Thrombolytic | |
3E08316 | Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous | |
3E08317 | Introduction of Other Thrombolytic into Heart, Percutaneous Approach | |
3E083G | Other Therapeutic Substance | |
3E083GC | Introduction of Other Therapeutic Substance into Heart, Percutaneous Approach | |
3E083K | Other Diagnostic Substance | |
3E083KZ | Introduction of Other Diagnostic Substance into Heart, Percutaneous Approach | |
3E083P | Platelet Inhibitor | |
3E083PZ | Introduction of Platelet Inhibitor into Heart, Percutaneous Approach | |
3E084 | Percutaneous Endoscopic | |
3E084G | Other Therapeutic Substance | |
3E084GC | Introduction of Other Therapeutic Substance into Heart, Percutaneous Endoscopic Approach | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |